Text Registration
Copyright Title
Generic Pharmaceutical Patent and FDA Law. 2013 Edition
Status
Published
on 20 Jun 2013
Year of Creation
2013
Copyright Claimant
Thomson Reuters Global Resources
Registration Number
TX0007744227
on 20 Jun 2013Copyright Summary
The U.S. Copyright record (Registration Number: TX0007744227) dated 20 Jun 2013, pertains to an electronic file (eService) titled "Generic Pharmaceutical Patent and FDA Law. 2013 Edition" created in 2013. The copyright holder is Thomson Reuters Global Resources, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Thomson Reuters Global Resources.
Application Details
Registration Number
TX0007744227
Registration Date
6/20/2013
Year of Creation
2013
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book, 923 p
First Publication Nation
United States
Preexisting Material
Some previously published material, including earlier versions
Notes
Rights Note: West, a Thomson Reuters business, Copyright Services, 610 Oppermand Drive, Eagan, MN, 55123, United States, (651) 687-6387, copyright.west@thomson.com
Material Matter Claimed Note: Original and revised text
Previous Registration Note: 2012, TX0007536699
Statements
Application Title Statement: Generic Pharmaceutical Patent and FDA Law. 2013 Edition
Author Statement: Shashank Upadhye Domicile: United States Authorship: Original and revised text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.